Methionine controls insulin/mammalian target of rapamycin complex 1 activity by modulating tuberous sclerosis complex

Seishu Gen1, Yu Matsumoto1, Tsukasa Suzuki1

  • 1Department of Agricultural Chemistry, Faculty of Applied Bioscience, Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagaya-ku, Tokyo, 156-8502, Japan.

Insights

Methionine impacts tumor suppressor TSC2 stability and lysosomal localization. Insulin signaling promotes TSC2 degradation when methionine is scarce, revealing a crosstalk mechanism.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Oncology

Background:

  • Tuberous sclerosis complex 2 (TSC2) is a tumor suppressor protein regulating cell growth.
  • TSC2 activity is influenced by growth factors, energy, oxygen, and insulin.
  • Mammalian target of rapamycin complex 1 (mTORC1) activation, often linked to cancer, is inhibited by TSC2.

Purpose of the Study:

  • To investigate the impact of methionine on the insulin/TSC2/mTORC1 signaling pathway.
  • To elucidate the relationship between methionine availability and TSC2 protein regulation.
  • To understand the crosstalk between insulin signaling and methionine metabolism via TSC2.

Main Methods:

  • Cellular assays to assess TSC2 protein stability and localization.
  • Analysis of TSC2 protein levels under varying methionine conditions.
  • Investigation of insulin signaling activation and its effect on TSC2 degradation.
  • Lysosomal localization studies for TSC2.

Main Results:

  • Methionine was found to influence TSC2 protein stability.
  • Methionine deprivation led to the abolition of TSC2 localization to the lysosome.
  • Insulin signaling activation promoted TSC2 degradation, particularly under methionine-deprived conditions.
  • Evidence of crosstalk between insulin and methionine metabolism mediated by TSC2 was established.

Conclusions:

  • Methionine plays a critical role in regulating TSC2 stability and cellular localization.
  • Insulin signaling and methionine availability interact through TSC2, affecting cell growth pathways.
  • This crosstalk mechanism involving TSC2, insulin, and methionine offers potential therapeutic targets for TSC2-related disorders.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
17.1K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.4K